Unfortunately, there was not only "old stuff" but "the early...

Unfortunately, there was not only "old stuff" but "the early next year" and "optimization" goes on and on! There is not yet FDA approved plan and only some 5 weeks to next fiscal year so perhaps the purpose was to tell "the early fiscal year", but who knows. For FDA discussions the plan needs to be clear and not "under optimization" and they told us already that these discussions are now in planning.
To get an oral presentation accepted to this meeting is a positive thing. The abstract needs to be sent some 4 or 5 months before the meeting and so you can have in the presentation only "old stuff" and so there cannot be many surprises for us. But the journal Neurology today gave the surprises, hope they are wrong. We should not get this kind of announcement from a journal but directly from the company.